ESLA Estrella Immunopharma falls 392 after Q1 2026 EPS misses analyst forecasts by a wide 906 margin CABR Caring Brands prioritizes home care segment expansion to boost longterm revenue and margin performance DMII AmDrug Acq2 leadership lays out key US pharma acquisition priorities in latest quarterly earnings release WHLR Wheeler shares drop 532 following Q2 2024 earnings release with no prior analyst consensus estimates Entergy ENO Sector Rotation Is Gilead Sciences GILD stock undervalued Q4 2025 Profit Exceeds Views